12493622|t|Prostaglandin E2 rescues cortical neurons from amyloid beta protein-induced apoptosis.
12493622|a|Cerebrospinal fluid prostaglandin E(2) (PGE(2)) levels are elevated in patients with Alzheimer's disease (AD), suggesting an involvement of PGE(2) in the neurodegeneration. AD is characterized by deposits of amyloid beta protein (Abeta) in various regions of the brain, e.g. the cerebral cortex. In the present study, we investigated the effects of PGE(2) on neuronal survival in primary cultures of rat cortical neurons. PGE(2) had no effect on neuronal cell viability or its morphology. Therefore, we examined the synergistic effects of PGE(2) with Abeta, a neurotoxin. Abeta caused neuronal cell death via apoptosis. PGE(2) significantly suppressed Abeta neurotoxicity, but did not promote the neurotoxicity. Furthermore, PGE(2) ameliorated Abeta-induced apoptotic features such as the condensation of chromatin and the fragmentation of DNA. Abeta increased the influx of Ca(2+) into neurons before cell death. Nimodipine, an inhibitor of the L-type voltage-sensitive calcium channel (L-VSCC), significantly reduced Abeta-potentiated Ca(2+) uptake. On the other hand, there was no effect on the Abeta-induced Ca(2+) influx by an N-VSCC blocker or P/Q-VSCC blockers. Moreover, the inhibitor of L-VSCC suppressed Abeta-induced neuronal cell death, whereas neither an N-VSCC blocker nor P/Q-VSCC blockers affected the neurotoxicity of Abeta. PGE(2) also suppressed the Abeta-induced Ca(2+) influx in a concentration-dependent manner. This study demonstrated that PGE(2) rescues cortical neurons from Abeta-induced apoptosis by reducing Ca(2+) influx in the primary culture. Furthermore, the present study suggested that the inhibition of L-VSCC contributes to the neuroprotective effect of PGE(2).
12493622	0	16	Prostaglandin E2	Chemical	MESH:D015232
12493622	107	125	prostaglandin E(2)	Chemical	MESH:D015232
12493622	127	133	PGE(2)	Chemical	MESH:D015232
12493622	158	166	patients	Species	9606
12493622	172	191	Alzheimer's disease	Disease	MESH:D000544
12493622	193	195	AD	Disease	MESH:D000544
12493622	227	233	PGE(2)	Chemical	MESH:D015232
12493622	241	258	neurodegeneration	Disease	MESH:D019636
12493622	260	262	AD	Disease	MESH:D000544
12493622	317	322	Abeta	Gene	351
12493622	436	442	PGE(2)	Chemical	MESH:D015232
12493622	487	490	rat	Species	10116
12493622	509	515	PGE(2)	Chemical	MESH:D015232
12493622	626	632	PGE(2)	Chemical	MESH:D015232
12493622	638	643	Abeta	Gene	351
12493622	659	664	Abeta	Gene	351
12493622	707	713	PGE(2)	Chemical	MESH:D015232
12493622	739	744	Abeta	Gene	351
12493622	745	758	neurotoxicity	Disease	MESH:D020258
12493622	784	797	neurotoxicity	Disease	MESH:D020258
12493622	812	818	PGE(2)	Chemical	MESH:D015232
12493622	831	836	Abeta	Gene	351
12493622	932	937	Abeta	Gene	351
12493622	962	968	Ca(2+)	Chemical	-
12493622	1001	1011	Nimodipine	Chemical	MESH:D009553
12493622	1106	1111	Abeta	Gene	351
12493622	1124	1130	Ca(2+)	Chemical	-
12493622	1185	1190	Abeta	Gene	351
12493622	1199	1205	Ca(2+)	Chemical	-
12493622	1237	1254	P/Q-VSCC blockers	Chemical	-
12493622	1301	1306	Abeta	Gene	351
12493622	1374	1391	P/Q-VSCC blockers	Chemical	-
12493622	1405	1418	neurotoxicity	Disease	MESH:D020258
12493622	1422	1427	Abeta	Gene	351
12493622	1429	1435	PGE(2)	Chemical	MESH:D015232
12493622	1456	1461	Abeta	Gene	351
12493622	1470	1476	Ca(2+)	Chemical	-
12493622	1550	1556	PGE(2)	Chemical	MESH:D015232
12493622	1587	1592	Abeta	Gene	351
12493622	1623	1629	Ca(2+)	Chemical	-
12493622	1777	1783	PGE(2)	Chemical	MESH:D015232
12493622	Negative_Correlation	MESH:D015232	351
12493622	Positive_Correlation	MESH:D020258	351
12493622	Association	MESH:D000544	351
12493622	Negative_Correlation	MESH:D009553	351
12493622	Positive_Correlation	MESH:D015232	MESH:D000544
12493622	Association	MESH:D015232	MESH:D019636

